NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:20
NeurAxis Total Assets (Quarterly) : 9.996M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.996M |
| March 31, 2026 | 8.746M |
| December 31, 2025 | 6.404M |
| September 30, 2025 | 5.776M |
| June 30, 2025 | 7.088M |
| March 31, 2025 | 3.030M |
| December 31, 2024 | 4.758M |
| September 30, 2024 | 1.143M |
| June 30, 2024 | 2.633M |
| March 31, 2024 | 0.9457M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.5095M |
| September 30, 2023 | 1.236M |
| June 30, 2023 | 1.540M |
| March 31, 2023 | 1.578M |
| December 31, 2022 | 1.481M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.7605M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 108.25B |
| AngioDynamics, Inc. | 241.93M |
| Alphatec Holdings, Inc. | 796.74M |
| AtriCure, Inc. | 717.54M |
| Baxter International, Inc. | 19.41B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.261M |
| Shareholders Equity (Quarterly) | 6.735M |
| Debt to Equity Ratio | 0.0415 |
| Current Ratio | 3.040 |
| Net Debt Paydown Yield | 0.02% |